Pretargeted brain PET imaging reveals amyloid-β pathology using a TCO-modified antibody and a fluorine-18-labeled tetrazine
Sara Lopes van den Broek, Jonas Eriksson, Qiaojun Yang, Nadja M Bucher, Eva Schlein, Lorenzo J I Balestri, Luke R Odell, Dag Sehlin, Stina Syvänen · 2025
Read Pretargeted brain PET imaging reveals amyloid-β pathology using a TCO-modified antibody and a fluorine-18-labeled tetrazine by Sara Lopes van den Broek, Jonas Eriksson, Qiaojun Yang, Nadja M Bucher, Eva Schlein, Lorenzo J I Balestri, Luke R Odell, Dag Sehlin, Stina Syvänen (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12742193.txt.
Description
Sara Lopes van den Broek and eight co-authors report a 2025 study of a two-step brain scan for the protein clumps tied to Alzheimer's disease. Antibodies can tag such proteins, but they cross into the brain poorly and move through the body slowly. That slowness has forced the use of long lived scan tracers.
The team split the scan into two steps. First they gave an antibody built to cross into the brain and to bind the clumps, fitted with a chemical handle. Later they gave a small tracer with a short lived tag that clicks onto that handle. This split lets the scan use a sharp, short lived tracer while the antibody takes its time.
Catalog record
| CREATOR | Sara Lopes van den Broek, Jonas Eriksson, Qiaojun Yang, Nadja M Bucher, Eva Schlein, Lorenzo J I Balestri, Luke R Odell, Dag Sehlin, Stina Syvänen |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 45 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |